Want to join the conversation?
Biopharmaceutical company $EBS said it expects 2015 revenue of $520-525MM, the midpoint of which represents 16% rise over 2014. This growth is driven by continued robust BioThrax sales, accounting for about $294MM. For 2015, $EBS expects GAAP EPS of $1.27-1.35, the midpoint of which represents 69% growth over 2014.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!